Filing Details

Accession Number:
0001437749-22-017793
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-07-26 16:38:04
Reporting Period:
2022-07-26
Accepted Time:
2022-07-26 16:38:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
946486 Windtree Therapeutics Inc WINT Biological Products, (No Disgnostic Substances) (2836) 943171943
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1716213 P. John Hamill 2600 Kelly Road
Suite 100
Warrington PA 18976
Svp & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-07-26 3,000 $0.37 72,800 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The shares were purchased in multiple trades at prices ranging from $0.3639 to $0.37. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.